Skip to content

Efficacy of Modified Putikadi Ointment and Ketoconazole in the treatment of Dadru (Tinea corporis).

Efficacy of Modified Putikadi Ointment and Ketoconazole in the treatment of Dadru (Tinea corporis).

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/10/046117
Enrollment
110
Registered
2022-10-03
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L089- Local infection of the skin and subcutaneous tissue, unspecified

Interventions

None listed

Sponsors

Dr Minakshi Urkude
Lead Sponsor
Dr Minakshi Urkude
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: The patients with classical lakshanas of Dadru will be included in the study.

Exclusion criteria

Exclusion criteria: 1) Tinea associated with other skin diseases will be excluded like eczema, scabies, psoriasis 2) Pregnant and lactating women will be excluded. 3) Other types of Tinea will be excluded.

Design outcomes

Primary

MeasureTime frame
Whether the Modified Putikadi ointment will give improvement from the symptoms of Dadrukushta.Timepoint: on 7th, 14th, 21st, 28th, 45th days

Secondary

MeasureTime frame
after completing the treatment any recurrence is foundTimepoint: after 35th day

Countries

India

Contacts

Public ContactDr Sonali Chalakh

Mahatma Gandhi Ayurved College Hospital and Research Centre Salod Wardha Maharashtra India

spchalakh@gmail.com9850366073

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026